These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6528127)

  • 1. Mechanisms initiating cellular proliferation.
    Olashaw NE; Pledger WJ
    Symp Fundam Cancer Res; 1984; 37():31-44. PubMed ID: 6528127
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-derived growth factor and autocrine mechanisms of oncogenic processes.
    Heldin CH; Westermark B
    Crit Rev Oncog; 1991; 2(2):109-24. PubMed ID: 1649642
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet-derived growth factor in autocrine transformation.
    Westermark B; Heldin CH
    Cancer Res; 1991 Oct; 51(19):5087-92. PubMed ID: 1655243
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth factors, oncogenes, and interferons.
    Friedman RM
    J Exp Pathol; 1986; 2(4):223-8. PubMed ID: 2431117
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interaction of growth factors and oncogenes in the tumorous transformation of cells].
    Ivashchenko IuD; Osipova LA
    Eksp Onkol; 1986; 8(2):9-17. PubMed ID: 3009133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors, oncogenes and transformation. Part I: Growth factors and cell cycle control.
    Paul D
    Arzneimittelforschung; 1985; 35(4):772-9. PubMed ID: 2990498
    [No Abstract]   [Full Text] [Related]  

  • 7. Human proto-oncogenes, growth factors, and cancer.
    Aaronson SA; Robbins KC; Tronick SR
    Symp Fundam Cancer Res; 1984; 37():241-55. PubMed ID: 6396789
    [No Abstract]   [Full Text] [Related]  

  • 8. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H; Fredriksson L; Li X; Eriksson U
    Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide growth factors and inflammation, tissue repair, and cancer.
    Sporn MB; Roberts AB
    J Clin Invest; 1986 Aug; 78(2):329-32. PubMed ID: 3525608
    [No Abstract]   [Full Text] [Related]  

  • 10. Origin and reversibility of malignancy.
    Sachs L
    Carcinog Compr Surv; 1985; 10():23-33. PubMed ID: 3904990
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular oncogenes, growth factors, and cellular growth control.
    Pardee AB; Campisi J; Gray HE; Dean M; Sonenshein G
    Symp Fundam Cancer Res; 1984; 37():21-9. PubMed ID: 6528125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factors and transformation.
    Roberts AB; Sporn MB
    Cancer Surv; 1986; 5(2):405-12. PubMed ID: 3779661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct mechanisms involving growth factors employed in subversion of growth regulation by oncogenes.
    Waterfield MD
    Prog Med Virol; 1985; 32():129-41. PubMed ID: 2991986
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth factors: mechanism of action and relation to oncogenes.
    Heldin CH; Westermark B
    Cell; 1984 May; 37(1):9-20. PubMed ID: 6373015
    [No Abstract]   [Full Text] [Related]  

  • 15. SHP-2 can suppress transformation induced by platelet-derived growth factor.
    Jazayeri A; McGee J; Shimamura T; Cross SB; Bejcek BE
    Exp Cell Res; 2000 Feb; 254(2):197-203. PubMed ID: 10640417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
    Dolnikov A; Ward RL; Hawkins NJ; Symonds G
    Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone-like tissue factors transforming cell growth].
    Farbiszewski R
    Postepy Biochem; 1984; 30(1-2):9-12. PubMed ID: 6597937
    [No Abstract]   [Full Text] [Related]  

  • 18. The platelet-derived growth factor: a perspective.
    Ross R
    Prog Clin Biol Res; 1981; 66 Pt A():503-6. PubMed ID: 7312873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanisms of malignant transformation].
    Feunteun J
    Bull Cancer; 1987; 74(3):233-40. PubMed ID: 3304477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
    Riese DJ; DiMaio D
    Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.